CrystalO Biopharma Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series AA

  • Investors
  • 9

CrystalO Biopharma General Information

Description

Manufacturer of membrane protein drugs intended for neuropsychiatric disorders, chronic kidney disease and cardiovascular disease. The company specailises in ion channel activity testing platforms, AI-based drug discovery tools, structure-guided compound design systems, preclinical validation models and molecular screening technologies, thereby improving therapeutic precision, accelerating drug development, and enhancing patient outcomes through technological innovation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 705, Building B, Innovation Plaza, Liulian Community
  • Pingshan Street, Pingshan District
  • Shenzhen, Guangdong 518000
  • China
+86 400
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Room 705, Building B, Innovation Plaza, Liulian Community
  • Pingshan Street, Pingshan District
  • Shenzhen, Guangdong 518000
  • China
+86 400

CrystalO Biopharma Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CrystalO Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series AA) 18-Sep-2025 Completed Generating Revenue
5. Later Stage VC 04-Mar-2025 Completed Generating Revenue
4. Later Stage VC (Series A) 09-Sep-2024 Completed Generating Revenue
3. Early Stage VC 07-Jan-2022 Completed Generating Revenue
2. Early Stage VC 24-Dec-2020 Completed Generating Revenue
1. Grant 12-Nov-2020 $53.8K Completed Generating Revenue
To view CrystalO Biopharma’s complete valuation and funding history, request access »

CrystalO Biopharma Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fuho Capital Venture Capital Minority
Triwise Capital Venture Capital Minority
Goldport Capital Venture Capital Minority
Guangdong Technology Financial Group Government Minority
HitGen Corporation Minority
You’re viewing 5 of 9 investors. Get the full list »

CrystalO Biopharma FAQs

  • When was CrystalO Biopharma founded?

    CrystalO Biopharma was founded in 2019.

  • Where is CrystalO Biopharma headquartered?

    CrystalO Biopharma is headquartered in Shenzhen, China.

  • What industry is CrystalO Biopharma in?

    CrystalO Biopharma’s primary industry is Drug Discovery.

  • Is CrystalO Biopharma a private or public company?

    CrystalO Biopharma is a Private company.

  • What is CrystalO Biopharma’s current revenue?

    The current revenue for CrystalO Biopharma is .

  • How much funding has CrystalO Biopharma raised over time?

    CrystalO Biopharma has raised $17.1M.

  • Who are CrystalO Biopharma’s investors?

    Fuho Capital, Triwise Capital, Goldport Capital, Guangdong Technology Financial Group, and HitGen are 5 of 9 investors who have invested in CrystalO Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process